Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers for precision medicine in airways disease.

Annals of the New York Academy of Sciences - 1 Jun 2015

Rooney Claire, Sethi Tariq

Abstract excerpt

Chronic obstructive pulmonary disease (COPD) is a complex clinical entity. In contrast to previously limited diagnostic definitions, it is now apparent that COPD is a clinically and biologically heterogeneous disease process, overlapping with other airways diseases like chronic asthma. As such, symptomatic response to current standard treatment practices is variable. New clinical guidelines have been altered to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Genomics
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Precision Medicine

Share to Proteins

Share to Pulmonary Disease, Chronic Obstructive

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 26099690
DOI: 10.1111/nyas.12809

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers for precision medicine in airways disease.PMID 26099690Read ↗

Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and PerspectivesSemantic proximity Read ↗

Chronic obstructive pulmonary disease phenotypes, biomarkers, and prognostic indicators.Semantic proximity Read ↗

Precision medicine in COPD: where are we and where do we need to go?Semantic proximity Read ↗

Biomarkers in chronic obstructive pulmonary disease.Semantic proximity Read ↗

[Biomarkers in COPD--do we need them?].Semantic proximity Read ↗

Biomarkers in the assessment and management of airways diseases.Semantic proximity Read ↗

Clinical Assessment and Utility of Biomarkers in Asthma-Chronic Obstructive Pulmonary Disease Overlap.Semantic proximity Read ↗

Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?Semantic proximity Read ↗

Current Approaches for Phenotyping as a Target for Precision Medicine in COPD Management.Semantic proximity Read ↗

Diagnosis, assessment, and phenotyping of COPD: beyond FEV₁.Semantic proximity Read ↗

Treatable traits: toward precision medicine of chronic airway diseases.Semantic proximity Read ↗

Precision medicine in airway diseases: moving to clinical practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.